Northern Trust Corp Uro Gen Pharma Ltd. Transaction History

Northern Trust Corp

$572 Billion
Q1 2024

A detailed history of Northern Trust Corp transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Northern Trust Corp holds 232,500 shares of URGN stock, worth $3.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

232,500

Previous 235,236 1.16%

Holding current value

$3.52 Million

Previous $3.53 Million 1.16%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$13.81 - $19.33 $37,784 - $52,886	-2,736 Reduced 1.16%	232,500 $3.49 Million
Q4 2023 Feb 13, 2024	BUY	$10.87 - $15.93 $628,775 - $921,470	57,845 Added 32.61%	235,236 $3.53 Million
Q3 2023 Nov 13, 2023	SELL	$8.84 - $22.64 $15,841 - $40,570	-1,792 Reduced 1.0%	177,391 $2.49 Million
Q2 2023 Aug 11, 2023	BUY	$8.75 - $14.29 $1.38 Million - $2.25 Million	157,725 Added 735.04%	179,183 $1.85 Million
Q1 2023 May 15, 2023	SELL	$7.99 - $11.02 $2,900 - $4,000	-363 Reduced 1.66%	21,458 $198,000

Q4 2022 Feb 13, 2023	SELL	$7.55 - $11.9 $1,336 - $2,106	-177 Reduced 0.8%	21,821 $193,000
Q3 2022 Nov 14, 2022	BUY	$7.21 - $9.41 $7,267 - $9,485	1,008 Added 4.8%	21,998 $183,000
Q2 2022 Aug 12, 2022	SELL	$5.12 - $8.74 $716,236 - $1.22 Million	-139,890 Reduced 86.95%	20,990 $172,000
Q1 2022 May 13, 2022	SELL	$5.92 - $9.73 $49,852 - $81,936	-8,421 Reduced 4.97%	160,880 $1.4 Million
Q4 2021 Feb 08, 2022	BUY	$9.03 - $19.13 $11,531 - $24,429	1,277 Added 0.76%	169,301 $1.61 Million
Q3 2021 Nov 15, 2021	SELL	$14.31 - $18.39 $422,574 - $543,056	-29,530 Reduced 14.95%	168,024 $2.83 Million
Q2 2021 Aug 13, 2021	SELL	$15.2 - $20.94 $148,078 - $203,997	-9,742 Reduced 4.7%	197,554 $3.02 Million
Q1 2021 May 12, 2021	SELL	$17.99 - $26.96 $577,191 - $864,984	-32,084 Reduced 13.4%	207,296 $4.04 Million
Q4 2020 Feb 11, 2021	SELL	$17.54 - $25.43 $115,465 - $167,405	-6,583 Reduced 2.68%	239,380 $4.31 Million
Q3 2020 Nov 16, 2020	BUY	$18.81 - $26.42 $907,469 - $1.27 Million	48,244 Added 24.4%	245,963 $4.75 Million
Q2 2020 Aug 14, 2020	SELL	$16.5 - $29.7 $533,082 - $959,547	-32,308 Reduced 14.05%	197,719 $5.17 Million
Q1 2020 May 14, 2020	BUY	$13.68 - $34.6 $30,971 - $78,334	2,264 Added 0.99%	230,027 $4.1 Million
Q4 2019 Feb 14, 2020	BUY	$21.11 - $34.86 $85,622 - $141,392	4,056 Added 1.81%	227,763 $7.6 Million
Q3 2019 Nov 13, 2019	BUY	$23.83 - $36.44 $4.01 Million - $6.14 Million	168,371 Added 304.27%	223,707 $5.33 Million
Q2 2019 Aug 13, 2019	BUY	$32.75 - $40.35 $954,400 - $1.18 Million	29,142 Added 111.25%	55,336 $1.99 Million
Q1 2019 May 13, 2019	BUY	$35.47 - $54.55 $304,900 - $468,911	8,596 Added 48.85%	26,194 $968,000
Q4 2018 Feb 12, 2019	BUY	$38.35 - $50.39 $61,360 - $80,624	1,600 Added 10.0%	17,598 $758,000
Q3 2018 Nov 14, 2018	BUY	$41.65 - $51.7 $99,960 - $124,080	2,400 Added 17.65%	15,998 $756,000
Q2 2018 Aug 14, 2018	BUY	$48.35 - $65.33 $657,463 - $888,357	13,598 New	13,598 $677,000

Others Institutions Holding URGN

# of Institutions

113

Shares Held

24M

Call Options Held

46.9K

Put Options Held

44.3K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $344M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Uro Gen Pharma Ltd. Transaction History